Back to search

University of South Florida

Development of antimicrobial guanidinylate polycarbonates

Abstract

dc:description

The World Health Organization (WHO) has identified the emergence of antibiotic resistance as one of the top 10 threats to public health. This is exemplified by serious threats such as methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant Enterococcus faecalis (VREF), and the urgent threat posed by Clostridioides difficile to human health. As part of a multifaceted combat strategy against these pathogenic bacteria, host-defense peptide (HDP)-mimicking polymers have proven to be resourceful and promising. However, a vast majority of antibiotic polymer applications were limited to topical applications due to their potential systematic toxicity. Herein, we report the design and synthesis of a series of novel biodegradable polymers – the lipidated antimicrobial guanidinylate polycarbonates. These novel polymers exhibit potent antimicrobial efficacy against both Gram-negative and Gram-positive bacteria, displaying rapid kinetic killing ability and a diminished propensity for resistance development. The bacterial killing process was found to be due to bacterial membrane disruptions, akin to the action mode of HDPs. Importantly, the optimal polymer showed significant antibacterial activity against C. difficile infection (CDI) in vivo through oral administration. In comparison to vancomycin, the standard CDI treatment, the synthesized polymer exhibits a prolonged therapeutic effect and notably reduces CDI recurrence rate. The convenient synthesis, easy scale-up, low cost, as well biodegradability of this class of polycarbonates, together with their in vitro antimicrobial activity and orally in vivo activity against CDI, suggested the great potential of lipidated guandinylate polycarbonates as a new class of antibacterial biomaterials to treat CDI and combat emerging antibiotic resistance. The length of the lipid tail has been modulated to achieve broad-spectrum activity while minimizing hemolytic effects. Moreover, we explored the synergistic potential of using N-Acetyl cysteine (NAC) in conjunction with lipidated guanidinylate polycarbonates. This combination has exhibited enhanced bacterial clearance and improved treatment efficacy, as well as potentiated the activity of the lipidated guanidinylate polycarbonates against both Gram-positive and Gram-negative bacteria, including resistant strains. The amalgamation of NAC and lipidated guanidinylate polycarbonates has also been proven efficacious in inhibiting biofilm formation. Results suggest the combination treatment of NAC and the lipidated guanidinylate polycarbonates may lead to the development of a novel class of antimicrobial agents.

Degree

thesis:*
Name thesis:degree_name
Doctor of Philosophy (Ph.D.)
Level thesis:degree_level
Dissertation
Discipline thesis:degree_discipline
Chemistry
Grantor
University of South Florida
Year dc:date
2023

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Xue, Menglin
Contributors dc:contributor
  • Jianfeng Cai, Ph.D.
  • Feng Cheng, Ph.D.
  • Kirpal Bisht, Ph.D.
  • Wenqi Liu, Ph.D.

Subjects

dc:subject × 5

Identifiers

dc:identifier.*
Repository record dc:identifier
https://digitalcommons.usf.edu/etd/10794

Chain of custody

source
Harvested from
University of South Florida
Base URL
digitalcommons.usf.edu/do/oai/
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
citation

Xue, Menglin. Development of antimicrobial guanidinylate polycarbonates. Dissertation thesis, University of South Florida, 2023. https://digitalcommons.usf.edu/etd/10794